198 related articles for article (PubMed ID: 22564836)
21. In vitro Synergistic Activity of Caspofungin Plus Polymyxin B Against Fluconazole-Resistant Candida glabrata.
Adams EK; Ashcraft DS; Pankey GA
Am J Med Sci; 2016 Mar; 351(3):265-70. PubMed ID: 26992255
[TBL] [Abstract][Full Text] [Related]
22. In vitro susceptibilities of Candida spp. to caspofungin: four years of global surveillance.
Pfaller MA; Boyken L; Hollis RJ; Messer SA; Tendolkar S; Diekema DJ
J Clin Microbiol; 2006 Mar; 44(3):760-3. PubMed ID: 16517851
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of aminocandin and caspofungin against Candida glabrata including isolates with reduced caspofungin susceptibility.
Brzankalski GE; Najvar LK; Wiederhold NP; Bocanegra R; Fothergill AW; Rinaldi MG; Pattterson TF; Graybill JR
J Antimicrob Chemother; 2008 Nov; 62(5):1094-100. PubMed ID: 18658194
[TBL] [Abstract][Full Text] [Related]
24. Assessment of caspofungin susceptibility of Candida glabrata by the Etest®, CLSI, and EUCAST methods, and detection of FKS1 and FKS2 mutations.
Bourgeois N; Laurens C; Bertout S; Balard Y; Krasteva D; Rispail P; Lachaud L
Eur J Clin Microbiol Infect Dis; 2014 Jul; 33(7):1247-52. PubMed ID: 24522619
[TBL] [Abstract][Full Text] [Related]
25. Echinocandin susceptibility testing of Candida species: comparison of EUCAST EDef 7.1, CLSI M27-A3, Etest, disk diffusion, and agar dilution methods with RPMI and isosensitest media.
Arendrup MC; Garcia-Effron G; Lass-Flörl C; Lopez AG; Rodriguez-Tudela JL; Cuenca-Estrella M; Perlin DS
Antimicrob Agents Chemother; 2010 Jan; 54(1):426-39. PubMed ID: 19884370
[TBL] [Abstract][Full Text] [Related]
26. Interlaboratory variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST methods: should the clinical laboratory be testing this agent?
Espinel-Ingroff A; Arendrup MC; Pfaller MA; Bonfietti LX; Bustamante B; Canton E; Chryssanthou E; Cuenca-Estrella M; Dannaoui E; Fothergill A; Fuller J; Gaustad P; Gonzalez GM; Guarro J; Lass-Flörl C; Lockhart SR; Meis JF; Moore CB; Ostrosky-Zeichner L; Pelaez T; Pukinskas SR; St-Germain G; Szeszs MW; Turnidge J
Antimicrob Agents Chemother; 2013 Dec; 57(12):5836-42. PubMed ID: 24018263
[TBL] [Abstract][Full Text] [Related]
27. Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance.
Xiao M; Fan X; Chen SC; Wang H; Sun ZY; Liao K; Chen SL; Yan Y; Kang M; Hu ZD; Chu YZ; Hu TS; Ni YX; Zou GL; Kong F; Xu YC
J Antimicrob Chemother; 2015 Mar; 70(3):802-10. PubMed ID: 25473027
[TBL] [Abstract][Full Text] [Related]
28. Comparison of the Sensititre YeastOne colorimetric antifungal panel with CLSI microdilution for antifungal susceptibility testing of the echinocandins against Candida spp., using new clinical breakpoints and epidemiological cutoff values.
Pfaller MA; Chaturvedi V; Diekema DJ; Ghannoum MA; Holliday NM; Killian SB; Knapp CC; Messer SA; Miskou A; Ramani R
Diagn Microbiol Infect Dis; 2012 Aug; 73(4):365-8. PubMed ID: 22726528
[TBL] [Abstract][Full Text] [Related]
29. Effects of Treated versus Untreated Polystyrene on Caspofungin In Vitro Activity against Candida Species.
Fothergill AW; McCarthy DI; Albataineh MT; Sanders C; McElmeel M; Wiederhold NP
J Clin Microbiol; 2016 Mar; 54(3):734-8. PubMed ID: 26763959
[TBL] [Abstract][Full Text] [Related]
30. Echinocandin Susceptibility Profile of Fluconazole Resistant Candida Species Isolated from Blood Stream Infections.
Deorukhkar SC; Saini S
Infect Disord Drug Targets; 2016; 16(1):63-8. PubMed ID: 26648186
[TBL] [Abstract][Full Text] [Related]
31. Activity of a long-acting echinocandin, CD101, determined using CLSI and EUCAST reference methods, against Candida and Aspergillus spp., including echinocandin- and azole-resistant isolates.
Pfaller MA; Messer SA; Rhomberg PR; Jones RN; Castanheira M
J Antimicrob Chemother; 2016 Oct; 71(10):2868-73. PubMed ID: 27287236
[TBL] [Abstract][Full Text] [Related]
32. Proof of Concept for MBT ASTRA, a Rapid Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS)-Based Method To Detect Caspofungin Resistance in Candida albicans and Candida glabrata.
Vatanshenassan M; Boekhout T; Lass-Flörl C; Lackner M; Schubert S; Kostrzewa M; Sparbier K
J Clin Microbiol; 2018 Sep; 56(9):. PubMed ID: 30021820
[TBL] [Abstract][Full Text] [Related]
33. Detection of caspofungin resistance in Candida spp. by Etest.
Desnos-Ollivier M; Dromer F; Dannaoui E
J Clin Microbiol; 2008 Jul; 46(7):2389-92. PubMed ID: 18448691
[TBL] [Abstract][Full Text] [Related]
34. Comparative in vitro activities of caspofungin and micafungin, determined using the method of the European Committee on Antimicrobial Susceptibility Testing, against yeast isolates obtained in France in 2005-2006.
Dannaoui E; Lortholary O; Raoux D; Bougnoux ME; Galeazzi G; Lawrence C; Moissenet D; Poilane I; Hoinard D; Dromer F;
Antimicrob Agents Chemother; 2008 Feb; 52(2):778-81. PubMed ID: 18070978
[TBL] [Abstract][Full Text] [Related]
35. Comparison between the EUCAST procedure and the Etest for determination of the susceptibility of Candida species isolates to micafungin.
Marcos-Zambrano LJ; Escribano P; Rueda C; Zaragoza Ó; Bouza E; Guinea J
Antimicrob Agents Chemother; 2013 Nov; 57(11):5767-70. PubMed ID: 23979756
[TBL] [Abstract][Full Text] [Related]
36. Antifungal activity of caspofungin in combination with amphotericin B against Candida glabrata: comparison of disk diffusion, Etest, and time-kill methods.
Kiraz N; Dag I; Yamac M; Kiremitci A; Kasifoglu N; Akgun Y
Antimicrob Agents Chemother; 2009 Feb; 53(2):788-90. PubMed ID: 19029317
[TBL] [Abstract][Full Text] [Related]
37. Correlation of MIC with outcome for Candida species tested against caspofungin, anidulafungin, and micafungin: analysis and proposal for interpretive MIC breakpoints.
Pfaller MA; Diekema DJ; Ostrosky-Zeichner L; Rex JH; Alexander BD; Andes D; Brown SD; Chaturvedi V; Ghannoum MA; Knapp CC; Sheehan DJ; Walsh TJ
J Clin Microbiol; 2008 Aug; 46(8):2620-9. PubMed ID: 18579718
[TBL] [Abstract][Full Text] [Related]
38. Dose escalation studies with caspofungin against Candida glabrata.
Domán M; Kovács R; Perlin DS; Kardos G; Gesztelyi R; Juhász B; Bozó A; Majoros L
J Med Microbiol; 2015 Sep; 64(9):998-1007. PubMed ID: 26296340
[TBL] [Abstract][Full Text] [Related]
39. Caspofungin-non-susceptible Candida isolates in cancer patients.
Kofteridis DP; Lewis RE; Kontoyiannis DP
J Antimicrob Chemother; 2010 Feb; 65(2):293-5. PubMed ID: 20016020
[TBL] [Abstract][Full Text] [Related]
40. Multicenter Study of Method-Dependent Epidemiological Cutoff Values for Detection of Resistance in Candida spp. and Aspergillus spp. to Amphotericin B and Echinocandins for the Etest Agar Diffusion Method.
Espinel-Ingroff A; Arendrup M; Cantón E; Cordoba S; Dannaoui E; García-Rodríguez J; Gonzalez GM; Govender NP; Martin-Mazuelos E; Lackner M; Lass-Flörl C; Linares Sicilia MJ; Rodriguez-Iglesias MA; Pelaez T; Shields RK; Garcia-Effron G; Guinea J; Sanguinetti M; Turnidge J
Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27799206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
